The chief expert at the World Health Organization, Somaya Swaminathan, said that the organization began discussions with Russia and requested safety and efficacy data for the Russian vaccine “Sputnik-V” against Corona.
Today, Monday, Swaminathan confirmed that the trial of the third phase of the Russian vaccine will be the most important test.
The scientist pointed out that the results of international experiments using blood plasma were not conclusive, and the evidence for their effectiveness is still very low.
For her part, the Director of the Health Programs Department at the World Health Organization, Rana Al-Hujjah, said earlier that the organization is in contact with the Russian authorities to learn about the developments of the “Sputnik-V” vaccine.
According to information received from the Russian State Medicines Registry, the vaccine will be intramuscularly injected using two carriers in two batches: the first – with the first carrier, and after three weeks – with the second carrier.
The Russian Ministry of Health said that the dual injection system allows the building of long-lasting immunity for up to two years.
On the eleventh of this month, Russia announced the registration of the world’s first vaccine against the Corona virus, and called it “Sputnik-V”.
Source: Agencies
